GSK pro­motes rou­tine im­mu­niza­tions for adults amid post-pan­dem­ic vac­cine back­slide

GSK launched a new ini­tia­tive on Thurs­day and com­mit­ted up to $1 mil­lion in grant fund­ing to im­prove adult rou­tine vac­ci­na­tion rates.

While the pan­dem­ic spot­light was trained on the race for nov­el Covid-19 vac­cines, oth­er rou­tine vac­ci­na­tion rates plum­met­ed, rais­ing con­cerns that missed dos­es may put chil­dren and even some adults at risk of pre­ventable dis­eases such as measles or shin­gles. The World Health Or­ga­ni­za­tion last year re­port­ed the largest drop in child­hood vac­ci­na­tions in rough­ly three decades.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.